Enterprise Value
$171.29 M
-$2.85 M-1.64%
Sat, 08 Feb 2025 00:45:51 GMT
Summary
- As of February 8, 2025, PLX enterprise value is $171.29 million, with a fall of -$2.85 million (-1.64%) during the most recent trading day.
- Over the past year, PLX enterprise value has increased by +$60.67 million (+54.85%).
- PLX enterprise value is now -94.25% below its all-time high of $2.98 billion.
Performance
PLX Enterprise Value Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Enterprise Value Formula
Enterprise Value = Market Cap + Total Debt − Cash & Cash Equivalents
PLX Enterprise Value Trends
| PeriodPeriod | Enterprise valueEnterprise value | Market capMarket cap | PricePrice |
|---|---|---|---|
| todaytoday | -1.6% | -1.4% | -1.4% |
| 1 m1 month | +20.8% | +18.1% | +18.1% |
| 3 m3 months | +162.9% | +122.1% | +122.1% |
| 6 m6 months | +124.5% | +162.4% | +162.1% |
| ytdytd | +46.8% | +39.4% | +39.4% |
| 1 y1 year | +54.9% | +78.8% | +77.1% |
| 5 y5 years | +80.7% | +273.8% | -24.7% |
PLX Enterprise Value Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | -1.6% | $137 M | +25.3% | |
| 3 m | 3-month | $174 M | -1.6% | $65 M | +162.9% |
| 6 m | 6-month | $174 M | -1.6% | $52 M | +230.0% |
| 1 y | 1-year | $174 M | -1.6% | $52 M | +230.0% |
| 3 y | 3-year | $220 M | -22.3% | $32 M | +437.9% |
| 5 y | 5-year | $324 M | -47.1% | $31 M | +445.8% |
| alltime | all time | $2.98 B | -94.3% | -$920 K | >+9999.0% |
Protalix BioTherapeutics Enterprise Value History
| Date | Value |
|---|---|
| 2025 | $171.29 M(+46.8%) |
| 2024 | $116.71 M(-16.5%) |
| 2023 | $139.80 M(+55.2%) |
| 2022 | $90.06 M(+178.8%) |
| 2021 | $32.30 M(-81.3%) |
| 2020 | $172.33 M(+87.7%) |
| 2019 | $91.80 M(+63.5%) |
| 2018 | $56.16 M(-41.4%) |
| 2017 | $95.89 M(+45.7%) |
| 2016 | $65.79 M(-32.5%) |
| 2015 | $97.52 M(-47.2%) |
| 2014 | $184.82 M(-46.3%) |
| 2013 | $344.33 M(-20.5%) |
| Date | Value |
|---|---|
| 2012 | $433.18 M(+9.6%) |
| 2011 | $395.15 M(-48.7%) |
| 2010 | $770.89 M(+69.8%) |
| 2009 | $453.90 M(+367.4%) |
| 2008 | $97.12 M(-50.4%) |
| 2007 | $195.82 M(-80.7%) |
| 2006 | $1.02 B(+4972.6%) |
| 2005 | $20.04 M(>+9900.0%) |
| 2004 | $20.00 K(-98.0%) |
| 2003 | $988.50 K(-303.2%) |
| 2002 | -$486.40 K(+99.3%) |
| 2001 | -$244.00 K(-170.5%) |
| 2000 | $346.18 K(-89.6%) |
| 1999 | $3.33 M |
FAQ
- What is Protalix BioTherapeutics enterprise value?
- What is the all time high enterprise value for Protalix BioTherapeutics?
- What is PLX enterprise value year-to-date change?
- What is Protalix BioTherapeutics enterprise value year-on-year change?
What is Protalix BioTherapeutics enterprise value?
The current enterprise value of PLX is $171.29 M
What is the all time high enterprise value for Protalix BioTherapeutics?
Protalix BioTherapeutics all-time high enterprise value is $2.98 B
What is PLX enterprise value year-to-date change?
Protalix BioTherapeutics enterprise value has changed by +$54.58 M (+46.77%) since the beginning of the year
What is Protalix BioTherapeutics enterprise value year-on-year change?
Over the past year, PLX enterprise value has changed by +$60.67 M (+54.85%)